FDA 483 - Enrico Bertini MD - May 05, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Clinical Investigator Enrico Bertini in Rome, Italy, revealed a significant issue regarding the maintenance of adequate case histories. The inspection found that source records and case report forms for a study, including data related to mFARS, walking tests, pharmacy activities, and investigator oversight, were not accurate, attributable, legible, complete, or contemporaneous. This indicates a serious concern with data integrity and record-keeping practices in the clinical investigation.
ID · 0d15c22d-86ad-4f8b-a5d3-03221efefa72